Edition:
United States

Soleno Therapeutics Inc (SLNO.OQ)

SLNO.OQ on NASDAQ Stock Exchange Capital Market

2.80USD
20 Jul 2018
Change (% chg)

$0.06 (+2.19%)
Prev Close
$2.74
Open
$2.77
Day's High
$2.84
Day's Low
$2.77
Volume
2,127
Avg. Vol
30,640
52-wk High
$3.70
52-wk Low
$1.35

Select another date:

Wed, May 16 2018

BRIEF-Soleno Therapeutics Q1 Loss Per Share $0.19

* SOLENO THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Soleno Therapeutics Says QTRLY Loss Per Share From Continuing Operations $0.17 - SEC Filing

* SOLENO THERAPEUTICS SAYS QTRLY LOSS PER SHARE FROM CONTINUING OPERATIONS $0.17 - SEC FILING

BRIEF-Soleno Therapeutics Announces Initiation Of Phase III Clinical Trial Of DCCR In Prader-Willi Syndrome

* SOLENO THERAPEUTICS ANNOUNCES INITIATION OF PHASE III CLINICAL TRIAL OF DCCR IN PRADER-WILLI SYNDROME

BRIEF-Soleno Therapeutics Reports Q4 Loss Per Share $0.43

* Q4 LOSS PER SHARE $0.39 FROM CONTINUING OPERATIONS Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-Soleno Therapeutics Announces Successful End-Of-Phase II Meeting With FDA For DCCR In Prader-Willi Syndrome

* SOLENO THERAPEUTICS ANNOUNCES SUCCESSFUL END-OF-PHASE II MEETING WITH FDA FOR DCCR IN PRADER-WILLI SYNDROME

BRIEF-Soleno Therapeutics Files For Resale Of Up To 14.2 Mln Shares

* SOLENO THERAPEUTICS INC FILES FOR RESALE OF UP TO 14.2 MILLION SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING Source text: (http://bit.ly/2DKTA0l) Further company coverage:

Select another date: